生活方式与心血管代谢性共病关联研究进展

韩雨廷; 孙至佳; 吕筠; 李立明

doi:10.16462/j.cnki.zhjbkz.2021.03.004

生活方式与心血管代谢性共病关联研究进展

doi: 10.16462/j.cnki.zhjbkz.2021.03.004

韩雨廷¹,
孙至佳¹,
吕筠^{1, 2},
李立明^{1, 2, ,}

1.
100191 北京，北京大学公共卫生学院流行病与卫生统计学系
2.
100191 北京，北京大学公众健康与重大疫情防控战略研究中心

基金项目:

国家自然科学基金 81941018

详细信息

通讯作者:
李立明，E-mail: lmleeph@vip.163.com

中图分类号: R587.1;R714.2
计量
- 文章访问数: 1427
- HTML全文浏览量: 664
- PDF下载量: 264
- 被引次数: 0
出版历程
- 收稿日期: 2021-01-19
- 修回日期: 2021-02-09
- 刊出日期: 2021-03-10

Progress in research on the association between lifestyle and cardiometabolic multimorbidity

HAN Yu-ting¹,
SUN Zhi-jia¹,
LYU Jun^{1, 2},
LI Li-ming^{1, 2
, ,}

1.
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
2.
Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China

Funds:

National Natural Science Foundation of China 81941018

More Information

Corresponding author: LI Li-ming, E-mail: lmleeph@vip.163.com

摘要

摘要: 共病高发于老年群体，可显著降低个人生活质量，增加疾病治疗、管理的难度和开支。随着人口老龄化进程的加速，共病逐渐成为居民健康的主要威胁。已有研究显示某些疾病因共享危险因素致病通路常聚集出现，心血管代谢性共病是其中最为常见和稳定的共病模式之一。促进健康生活方式是健康管理和疾病管理的重要手段，其对单一心血管代谢性疾病发病风险的保护效力已被大量研究证实。近年来研究者开始探索生活方式与心血管代谢性共病之间的关联。本文就心血管代谢性共病的定义、流行分布和共病机制以及综合生活方式与心血管代谢性共病间关联的前瞻性研究证据进行综述。
- 生活方式 /
- 心血管代谢性疾病 /
- 共病 /
- 关联研究
Abstract: Multimorbidity is common among the aging population. It significantly decreases the quality of life and increases the complexity and costs for disease treatment and management. With the acceleration of population aging, multimorbidity has gradually become the main threat to health. Prior studies have demonstrated that some diseases often co-occur due to shared risk factors and pathogenic pathways. Cardiometabolic multimorbidity is one of the most common and stable multimorbidity profiles. Adherence to a healthy lifestyle, as a crucial way for health management and disease management, has proven to be efficient for preventing single cardiometabolic diseases. In recent years, researchers have been exploring the association between lifestyle factors and the risk of cardiometabolic multimorbidity. In this article, the definition, distribution, and mechanism of cardiometabolic multimorbidity are reviewed and current evidence from prospective studies on association for the combined lifestyle factors with cardiometabolic multimorbidity is discussed.
- Lifestyle /
- Cardiometabolic disease /
- Multimorbidity /
- Association study

HTML全文

图 1 心血管代谢性疾病发生发展示意图

Figure 1. Progression of cardiometabolic disease

下载: 全尺寸图片幻灯片

参考文献(41)

[1]	Han YT, He Y, Lv J, et al. Aging in China: perspectives on public health[J]. Global Health Journal, 2020, 4(1): 11-17. DOI: 10.1016/j.glohj.2020.01.002.
[2]	Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies[J]. PLoS One, 2014, 9(7): e102149. DOI: 10.1371/journal.pone.0102149.
[3]	The Academy of Medical Sciences. Multimorbidity: a priority for global health research[R]. The Academy of Medical Sciences, 2018. https://acmedsci.ac.uk/policy/policy-projects/multimorbidity.
[4]	Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature[J]. Ageing Res Rev, 2011, 10(4): 430-439. DOI: 10.1016/j.arr.2011.03.003.
[5]	Smith SM, Soubhi H, Fortin M, et al. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings[J]. BMJ, 2012, 345: e5205. DOI: 10.1136/bmj.e5205.
[6]	Blakely T, Kvizhinadze G, Atkinson J, et al. Health system costs for individual and comorbid noncommunicable diseases: an analysis of publicly funded health events from New Zealand[J]. PLoS Med, 2019, 16(1): e1002716. DOI: 10.1371/journal.pmed.1002716.
[7]	Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, et al. Multimorbidity patterns: a systematic review[J]. J Clin Epidemiol, 2014, 67(3): 254-266. DOI: 10.1016/j.jclinepi.2013.09.021.
[8]	Busija L, Lim K, Szoeke C, et al. Do replicable profiles of multimorbidity exist? Systematic review and synthesis[J]. Eur J Epidemiol, 2019, 34(11): 1025-1053. DOI: 10.1007/s10654-019-00568-5.
[9]	Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, et al. Association of cardiometabolic multimorbidity with mortality[J]. JAMA, 2015, 314(1): 52-60. DOI: 10.1001/jama.2015.7008.
[10]	Freisling H, Viallon V, Lennon H, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study[J]. BMC Med, 2020, 18(1): 5. DOI: 10.1186/s12916-019-1474-7.
[11]	Kang YM, Cho YK, Lee SE, et al. Cardiovascular diseases and life expectancy in adults with type 2 diabetes: a Korean national sample cohort study[J]. J Clin Endocrinol Metab, 2017, 102(9): 3443-3451. DOI: 10.1210/jc.2017-00643.
[12]	Kivimäki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe[J]. Lancet Public Health, 2017, 2(6): e277-e285. DOI: 10.1016/s2468-2667(17)30074-9.
[13]	Singh-Manoux A, Fayosse A, Sabia S, et al. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: a cohort study[J]. PLoS Med, 2018, 15(5): e1002571. DOI: 10.1371/journal.pmed.1002571.
[14]	Xu X, Mishra GD, Dobson AJ, et al. Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: a 20-year cohort study[J]. PLoS Med, 2018, 15(3): e1002516. DOI: 10.1371/journal.pmed.1002516.
[15]	Zhang D, Tang X, Shen P, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study[J]. BMJ Open, 2019, 9(3): e024476. DOI: 10.1136/bmjopen-2018-024476.
[16]	Krokstad S, Ding D, Grunseit AC, et al. Multiple lifestyle behaviours and mortality, findings from a large population-based Norwegian cohort study-The HUNT Study[J]. BMC Public Health, 2017, 17(1): 58. DOI: 10.1186/s12889-016-3993-x.
[17]	Rosen H. Is obesity a disease or a behavior abnormality? Did the AMA get it right?[J]. Mo Med, 2014, 111(2): 104-108.
[18]	Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond[J]. Circulation, 2010, 121(4): 586-613. DOI: 10.1161/circulationaha.109.192703.
[19]	Eguchi E, Iso H, Tanabe N, et al. Is the association between healthy lifestyle behaviors and cardiovascular mortality modified by overweight status? The Japan Collaborative Cohort Study[J]. Prev Med, 2014, 62: 142-147. DOI: 10.1016/j.ypmed.2013.12.004.
[20]	Li Y, Ley SH, Tobias DK, et al. Birth weight and later life adherence to unhealthy lifestyles in predicting type 2 diabetes: prospective cohort study[J]. BMJ, 2015, 351: h3672. DOI: 10.1136/bmj.h3672.
[21]	Agha G, Loucks EB, Tinker LF, et al. Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study[J]. J Am Coll Cardiol, 2014, 64(17): 1777-1785. DOI: 10.1016/j.jacc.2014.07.981.
[22]	Sakakibara BM, Obembe AO, Eng JJ. The prevalence of cardiometabolic multimorbidity and its association with physical activity, diet, and stress in Canada: evidence from a population-based cross-sectional study[J]. BMC Public Health, 2019, 19(1): 1361. DOI: 10.1186/s12889-019-7682-4.
[23]	Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775, 385 individuals and 12, 539 strokes[J]. Lancet, 2014, 383(9933): 1973-1980. DOI: 10.1016/S0140-6736(14)60040-4.
[24]	Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part Ⅰ[J]. Eur Heart J, 2013, 34(31): 2436-2443. DOI: 10.1093/eurheartj/eht149.
[25]	Mozaffarian D, Marfisi R, Levantesi G, et al. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors[J]. Lancet, 2007, 370(9588): 667-675. DOI: 10.1016/S0140-6736(07)61343-9.
[26]	Thompson PD, Panza G, Zaleski A, et al. Statin-associated side effects[J]. J Am Coll Cardiol, 2016, 67(20): 2395-2410. DOI: 10.1016/j.jacc.2016.02.071.
[27]	Lv J, Yu C, Guo Y, et al. Adherence to a healthy lifestyle and the risk of type 2 diabetes in Chinese adults[J]. Int J Epidemiol, 2017, 46(5): 1410-1420. DOI: 10.1093/ije/dyx074.
[28]	Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J]. J Am Coll Cardiol, 2017, 69(9): 1116-1125. DOI: 10.1016/j.jacc.2016.11.076.
[29]	D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study[J]. Circulation, 2008, 117(6): 743-753. DOI: 10.1161/CIRCULATIONAHA.107.699579.
[30]	Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, et al. Hypertension and diabetes mellitus: coprediction and time trajectories[J]. Hypertension, 2018, 71(3): 422-428. DOI: 10.1161/HYPERTENSIONAHA.117.10546.
[31]	Qi Q, Liang L, Doria A, et al. Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts[J]. Diabetes, 2012, 61(3): 745-752. DOI: 10.2337/db11-1254.
[32]	Bell JA, Hamer M, Batty GD, et al. Incidence of metabolic risk factors among healthy obese adults: 20-year follow-up[J]. J Am Coll Cardiol, 2015, 66(7): 871-873. DOI: 10.1016/j.jacc.2015.06.014.
[33]	Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes[J]. Lancet, 2017, 389(10085): 2239-2251. DOI: 10.1016/s0140-6736(17)30058-2.
[34]	Tune JD, Goodwill AG, Sassoon DJ, et al. Cardiovascular consequences of metabolic syndrome[J]. Transl Res, 2017, 183: 57-70. DOI: 10.1016/j.trsl.2017.01.001.
[35]	Zhang Y, Pan XF, Chen J, et al. Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies[J]. Diabetologia, 2020, 63(1): 21-33. DOI: 10.1007/s00125-019-04985-9.
[36]	Liu G, Li Y, Hu Y, et al. Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus[J]. J Am Coll Cardiol, 2018, 71(25): 2867-2876. DOI: 10.1016/j.jacc.2018.04.027.
[37]	Strelitz J, Ahern AL, Long GH, et al. Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality[J]. Cardiovasc Diabetol, 2019, 18(1): 98. DOI: 10.1186/s12933-019-0902-5.
[38]	Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes[J]. N Engl J Med, 2003, 348(5): 383-393. DOI: 10.1056/NEJMoa021778.
[39]	The Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial[J]. Arch Intern Med, 2010, 170(17): 1566-1575. DOI: 10.1001/archinternmed.2010.334.
[40]	The Look AHEAD Research Group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes[J]. N Engl J Med, 2013, 369(2): 145-154. DOI: 10.1056/NEJMoa1212914.
[41]	Chudasama YV, Khunti K, Gillies CL, et al. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: a longitudinal cohort study[J]. PLoS Med, 2020, 17(9): e1003332. DOI: 10.1371/journal.pmed.1003332.